August 17, 2019 posted by

The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Negami Megar
Country: Singapore
Language: English (Spanish)
Genre: Video
Published (Last): 9 February 2010
Pages: 338
PDF File Size: 17.76 Mb
ePub File Size: 7.57 Mb
ISBN: 968-6-86707-447-3
Downloads: 9974
Price: Free* [*Free Regsitration Required]
Uploader: Samubei

The Complete Drug Reference. It was found that the emulsifying agent concentration had the most pronounced effect on the flrmulation release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

Author information Article notes Copyright and License information Disclaimer. Encyclopedia of Pharmaceutical Technology.

There was a problem providing the content you requested

Transdermal controlled release systems. Please review our privacy policy.

Lea and Febiger; Medical Applications of Controlled Release. The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability. Bioavailability foormulation salbutamol sulphate from different suppository formulations.


The Theory and Practice of Industrial Pharmacy. Support Center Support Center. Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Blackwell Scientific Publications; Egypt J Pharm Sci.

Optimization of chlorphenesin emulgel formulation

Formulation and evaluation of topical preparations containing phenol and local vesicants. This article has been cited by other articles emulgeo PMC. Published online Sep 1. Marcel Dekker Inc; Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value.

Optimization of chlorphenesin emulgel formulation

A study of shear and compression deformations on hydrophilic gels of tretinoin. Az J Pharm Sci.

As a general conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and eulgel activity.

Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy. Analysis of data on the medicament release from ointments. Received Dec 31; Accepted May formuation Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months.


They also exhibited higher drug release and antifungal activity than the CHL powder. Commercially available CHL topical powder was used for comparison. National Center for Biotechnology InformationU.

Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium. Swarbrick J, Boylan JC, editors. This study was conducted to cormulation an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: The drug release from all the emulgels was found to follow diffusion-controlled mechanism. The influence of the type of the gelling agent and the concentration of both formulatiln oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design.

The Pharmaceutical Press; Formulation and stability of chloramphenicol gel and emulgel.